Worldwide Healthcare Trust (WWH), formerly known as Finsbury Worldwide Pharmaceutical, is a large British closed-ended investment fund, dedicated to investments in healthcare and biotechnology companies worldwide with the objective of achieving a high level of capital growth. Launched by Frostrow Capital LLP and managed by OrbiMed Capital LLC, it seeks to invest in growth stocks of large-cap companies with a market capitalisation of at least $5 billion. The Trust uses derivative and gearing transactions. It invests about 60% of the portfolio in larger companies, and at around 20% in smaller companies. When creating its portfolio, the fund utilises fundamental analysis with a bottom-up stock picking approach. Worldwide Healthcare Trust is known to benchmark its portfolio performance against the MSCI World Healthcare Index. The Worldwide Healthcare share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
Check out Capital.com for the latest WWH share price.
Latest shares articles
Eurozone CPI holds steady, reinforcing ECB’s wait-and-see approach
Eurozone inflation remained unchanged in July which enabled the European Central Bank to keep rates unchanged for the foreseeable future
09:29, 1 August 2025
Amazon Q2 Earnings Preview: tariffs, mixed demand and AWS under scrutiny
Signs of further AI monetisation could push Amazon shares towards all time highs.
14:02, 31 July 2025
Forex CFDs: Understanding currency forwards vs spot markets
Spot or forward? These two forex markets behave differently, and now you can trade both with us as forex CFDs. Here’s how they work, and what sets them apart.
13:08, 31 July 2025
US labour data could give more context to a stronger-than-expected GDP in Q2
The US labour market is expected to have cooled in July as a stronger-than-expected Q2 GDP print surprised markets
12:17, 31 July 2025
Ratings and Reviews
Ratings and Reviews
